P-174 MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma: Trial in progress

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Strickler, J; Nakamura, Y; Shitara, K; Catenacci, D; Janjigian, Y; Barzi, A; Bekaii-Saab, T; Lenz, H; Lee, J; Van Cutsem, E; Chung, H; Tabernero, J; Yoshino, T; Siena, S; Garrido-Mayor, J; Palanca-Wessels, M; Xie, D; Marshall, J

Published Date

  • July 2021

Published In

Volume / Issue

  • 32 /

Start / End Page

  • S159 - S159

Published By

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1016/j.annonc.2021.05.229